Abstract
The cytokine tumor necrosis factor (TNF)α induces caspase-dependent cell death in a subset of tumor cells. In this report, we show a novel suppressive effect of calpeptin, a calpain inhibitor, on TNFα-induced cell death and accumulation of p53 in L929 mouse fibrosarcoma. Exposure to 10 ng/ml TNFα induced cell death in >50% of L929 cells within 12 h and stimulated accumulation of p53 (8-fold). Preincubation of cells with calpeptin blocked both TNFα-induced cell death and accumulation of p53 as examined with Western blot. TNFα-induced accumulation of p53 was in part contributed by increase of p53 mRNA level (2.2-fold) in a calpeptin-insensitive manner. Interestingly, other calpain inhibitors tested did not show these effects like calpeptin and TNFα treatment did not increase apparent calpain activity in L929 cells, suggesting that calpeptin may have another function besides targeting calpain. Expression of dominant negative mutant p53Val135 reduced the incidence of TNFα-mediated cell death. Taken together, our findings suggest that TNFα induces calpeptin-dependent, but calpain-independent accumulation of p53 protein as a necessary step leading to death in L929 cells.
Similar content being viewed by others
References
Tracey KJ, Cerami A Tumor necrosis factor, other cytokine and disease. Annu Rev Cell Biol 1993; 9: 317–343.
Vandevoorde V, Haegeman G, Fiers W Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effect. J Cell Biol 1997; 137: 1627–1638.
White E Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10: 1–15.
Sidoti-de Fraisse C, Rincheval V, Risler Y, Mignotte B, Vayssiere JL TNF-α activates at least two apoptotic signaling cascades. Oncogene 1998; 17: 1639–1651.
Grooten J, Goossens V, Vanhaesebroeck B, Fiers W Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: Early events in tumor necrosis factorinduced cytotoxicity. Cytokine 1993; 5: 546–555.
Fiers W, Beyaert R, Boone E, et al TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflamm 1996; 47: 67–75.
Vercammen D, Brouckaert G, Denecker G, et al Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998; 188: 919–930.
Vercammen D, Beyaert R, Denecker G, et al Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998; 187: 1477–1485.
Shoji Y, Uedono Y, Ishikura H, Takeyama N, Tanaka T DNA damage induced by tumor necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation. Immunology 1995; 84: 543–548.
Trent JC, McConkey DJ, Loughlin SM, Harbison MT, Fernandez A, Ananthaswamy HN Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J 1996; 15: 4497–4505.
Baker SJ, Reddy EP Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17: 3216–3270.
Clarke AR, Purdie CA, Harrison DJ, et al Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849–852.
Oren M Regulation of p53 tumor suppressor protein. J Biol Chem 1999; 274: 36031–36034.
Allan LA, Fried M p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis. Oncogene 1999; 18: 5403–5412.
Li PF, Dietz R, von Harsdorf R p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 1999; 18: 6027–6036.
Prives C Signaling to p53: Breaking the MDM2-p53 circuit. Cell 1998; 95: 5–8.
Haupt Y, Maya R, Kazaz A, Oren M Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296–299.
Kubbutat MH, Jones SN, Vousden KH Regulation of p53 stability by Mdm2. Nature 1997; 387: 299–303.
Hale TK, Braithwaite AW The adenovirus oncoprotein E1a stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene. J Biol Chem 1999; 274: 23777–23786.
El-Deiry WS, Tokino T, Velculescu VE, et al WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825.
Barak YM, Juven T, Haffner R, Oren M Mdm2 expression is induced by wild type p53 activity. EMBO J 1993; 12: 461–468.
Hermeking H, Lengauer C, Polyak K, et al 14–3–3 σ is a p53-regulated inhibitor of G2/M progression. Molecular Cell 1997; 1: 3–11.
Miyashita T, Reed JC Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293–299.
Israeli D, Tessler E, Haupt Y, et al A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J 1997; 16: 4384–4392.
Wu GS, Burns TF, McDonald 3rd ER, et al Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest. Oncogene 1999; 18: 6411–6418.
Yeung MC, Lau AS Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKRmediated apoptosis pathway in human promonocytic U937 cells. J Biol Chem 1998; 273: 25198–25202.
Donato NJ, Perez M Tumor necrosis factor-induced apoptosis stimulates p53 accumulation and p21WAF proteolysis in ME-180 cells. J Biol Chem 1998; 273: 5067–5072.
Juven T, Barak Y, Zauberman A, George DL, Oren M Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 1993; 12: 3411–3416.
Zauberman A, Oren M, Zipori D Involvement of p21(WAF1/ Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition. Oncogene 1997; 15: 1705–1711.
Gannon JV, Greaves R, Iggo R, Lane DP Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9: 1595–1602.
Knepper-Nicolai B, Savill J, Brown SB Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases. J Biol Chem 1998; 273: 30530–30536.
Wood DE, Newcomb EW Caspase-dependent activation of calpain during drug-induced apoptosis. J Biol Chem 1999; 274: 8309–8315.
Ashkenazi A, Dixit VM Death receptors: Signaling and modulation. Science 1998; 281: 1305–1308.
Hirai S, Kawasaki H, Yaniv M, Suzuki K Degradation of transcription factors, c-Jun and c-Fos, by calpain. FEBS Lett 1991; 287: 57–61.
Wood DE, Thomas A, Devi LA, et al Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 1998; 17: 1069–1078.
Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR Tumor necrosis factor-α-inducible IκBα proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitinproteasome pathway for nuclear factor-κB activation. J Biol Chem 1999; 274: 787–794.
Ruiz-Vela A, Gonzalez de Buitrago G, Martinez-A C Implication of calpain in caspase activation during B cell clonal deletion. EMBO J 1999; 18: 4988–4998.
Debiasi RL, Squier MK, Pike B, et al Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J Virol 1999; 73: 695–701.
Wang KK Developing selective inhibitors of calpain. Trends Pharmacol Sci 1990; 11: 139–142.
Schoenwaelder SM, Burridge K Evidence for a calpeptin protein-tyrosine phosphatase upstream of the small GTPase rho. J Biol Chem 2000; 274: 14359–14367.
Caelles C, Helmberg A, Karin M p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994; 370: 220–223.
Sun X, Shimizu H, Yamamoto K Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol Cell Biol 1995; 15: 4489–4496.
Roy B, Beamon J, Balint E, Reisman D Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol Cell Biol 1994; 14: 7805–7815.
Tanaka N, Kawakami T, Taniguchi T Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol 1993; 13: 4531–4538.
Pomerantz J, Schreiber-Agus N, Liegeois NJ, et al The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizesMDM2's inhibition of p53. Cell 1998; 92: 713–723.
Zhang Y, Xiong Y, Yarbrough WG ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both Rb and p53 tumor suppression pathways. Cell 1998; 92: 725–734.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, B.J., Jung, Y.K. Calpeptin suppresses tumor necrosis factor-α-induced death and accumulation of p53 in L929 mouse sarcoma cells. Apoptosis 7, 115–121 (2002). https://doi.org/10.1023/A:1014354229159
Issue Date:
DOI: https://doi.org/10.1023/A:1014354229159